
Release date: 2026-07-08 11:17:28 Article From: Lucius Laos Recommended: 246
Laos's pharmaceutical industry started late and remains relatively small in scale; for a long time, domestic drug supply has relied on imports from China, India, and other countries. In recent years, as Laos has increased its opening-up and introduced preferential policies, a number of pharmaceutical companies have chosen to establish factories here, and the sector has shown certain growth momentum. In 2026, Laos officially graduated from the Least Developed Country (LDC) status, and its drug registration standards have been upgraded from the WHO prequalification pathway to ICH standards, with GMP requirements raised simultaneously. The following is an overview of the main legitimate pharmaceutical manufacturers currently operating in Laos.
Lucius Pharmaceuticals (Laos) Co., Ltd. was established in 2020 and is headquartered at No. 26, Thongmang Village, Xaythany District, Vientiane Capital, Laos. As a representative enterprise in Laos's generic drug sector, Lucius Pharmaceuticals originates from its parent company based in Hyderabad, India.
Production Scale: The factory covers an area of approximately 210,000 square meters and houses the Asia-Pacific No.1 Smart Factory, equipped with cutting-edge pharmaceutical machinery from China, the United States, Germany, and other countries, with an annual production capacity exceeding 1.5 billion tablets.
Product Portfolio: Currently produces over 200 generic drugs, covering multiple therapeutic areas including oncology, cardiovascular diseases, diabetes, hematology, dermatology, men's health, and anti-aging. As of June 2024, it has obtained marketing authorizations for 54 anti-cancer drugs, including generic versions of targeted therapies such as sotorasib, osimertinib, cabozantinib, and ivosidenib.
Certifications: Has obtained GMP certification from the Lao Ministry of Health, and its products are registered and approved by the Food and Drug Administration under the Lao Ministry of Health, granting legal production and sales qualifications. In October 2023, the World Health Organization conducted a comprehensive inspection of the Lucius Pharmaceuticals factory and confirmed that it fully complies with WHO standards.
Market Presence: Business has expanded to 12 countries including Thailand, Indonesia, Cambodia, Vietnam, the Philippines, Singapore, Malaysia, Japan, and China.
ASEAN (Laos) Pharmaceutical and Food Co., Ltd. was established in 2012 and is the first pharmaceutical company in Laos to obtain GMP certification. The company currently holds more than 50 approved drug products, covering oncology, chronic diseases, infectious diseases, and other fields.
Element Pharma (Laos) Co., Ltd. was founded in 2019 and is located in the Boten Special Economic Zone, Laos. The company was established with the participation of the technical team from the Artificial Intelligence Bio-medical Technology Research Institute of Nanjing University in China, with a factory area of 2,500 square meters. Element Pharma focuses on the generic manufacturing, production, and sales of anti-tumor and men's health drugs, and has currently exported pharmaceutical products to more than 120 countries and regions across Asia, Africa, Europe, and Latin America.
Laos United Pharmaceutical Group was founded in 2017 as a comprehensive pharmaceutical enterprise integrating R&D, production, and sales. It is currently the largest pharmaceutical company in Laos, accounting for approximately 27% of the domestic drug market share. The Second State Pharmaceutical Factory of Laos was established in the 1970s as a state-owned enterprise directly under the Lao Ministry of Health, producing over 160 types of drugs including infusions, injections, oral tablets, and capsules. Other players include Daewoong Pharmaceuticals, the Third Pharmaceutical Factory of Laos, and others.
Overall, the pharmaceutical industry in Laos is in a phase of rapid development. A number of legitimate manufacturers, represented by Lucius Pharmaceuticals, have formed large-scale production capabilities and have obtained official Lao GMP certifications and product registration numbers.
In recent years, leveraging the World Trade Organization (WTO) patent waiver for least-developed countries (extended to July 1, 2033), Laos has been legally permitted to produce ge···【more】
Recommended:141Release date: 2026-08-05
How Can Chinese Patients Access Generic Drugs from Laos?In recent years, generic drugs from Laos have gradually entered the view of Chinese cancer and chronic disease patients due ···【more】
Recommended:143Release date: 2026-08-04
Leveraging the WTO patent waiver for least-developed countries (extended to 2033), Laos has seen rapid growth in its generic pharmaceutical industry in recent years. Lucius Pharmac···【more】
Recommended:196Release date: 2026-07-31
Lucius Pharmaceutical is a modern pharmaceutical enterprise headquartered in Vientiane, the capital of Laos. The company was established in 2020, with its R&D and operational s···【more】
Recommended:158Release date: 2026-07-28
Lucius Pharmaceuticals Relocates from India to Laos: A Five-Year Development Journey of a Generic Drug CompanyRelocation Background and Strategic ShiftLucius Pharmaceuticals was fo···【more】
Recommended:252Release date: 2026-07-24
In recent years, Laos has gradually become a major global supply source for generic drugs, leveraging the WTO-granted patent exemption for least-developed countries. Among them, Lu···【more】
Recommended:198Release date: 2026-07-22
Company Overview: Industrial Migration from India to LaosLucius Pharmaceuticals (Laos) Co., Ltd. was established in 2020, with its headquarters located at No. 26, Thongmang Village···【more】
Recommended:211Release date: 2026-07-20
Lucius Pharmaceutical is one of the representative generic drug enterprises in Laos. The company was established in Vientiane, the capital of Laos, in 2020 and has been in operatio···【more】
Recommended:227Release date: 2026-07-17
Industrial Rise: From Zero to a "World Pharmacy" CandidateThe explosive growth of Laos' generic drug industry is rooted in unique international rule dividends. As a U···【more】
Recommended:349Release date: 2026-07-16
In recent years, Laos generic drugs have gradually come into view of oncology and chronic disease patients in China due to their significant price advantage. Leveraging the WTO pat···【more】
Recommended:197Release date: 2026-07-15
Regulatory System: From "One Ministry, One Department" to Legal AmendmentsLao drug regulation adopts a centralized "one ministry, one department" management mod···【more】
Recommended:260Release date: 2026-07-14
Overview of Lao generic drug industryThe Lao generic drug industry started late but has developed rapidly in recent years. Relying on the WTO's patent waiver for least develope···【more】
Recommended:270Release date: 2026-07-09
Dr. Louis, a microbiologist at the World Health Organization (WHO), recently made a technical visit to Lucius Pharmaceuticals in Laos. The purpose of the visit was to learn more ab···【more】
Recommended:894Release date: 2024-07-09
Lung cancer is the most rapidly increasing malignant tumor with the fastest increasing morbidity and mortality, which has been troubling medical workers. Clinical studies have foun···【more】
Recommended:841Release date: 2024-07-09
Lucius Pharmaceuticals Version of Vibegron Now Available1.Basic Drug InformationVibegron (generic name: vibegron) is an oral, once-daily β3-adrenergic receptor agonist approved by ···【more】
Recommended:125Release date: 2026-08-06
Lucius Pharmaceuticals version of Ibrutinib is now availableIn a randomized controlled trial of 269 previously untreated CLL/SLL patients aged 65 years and older, ibrutinib demonst···【more】
Recommended:118Release date: 2026-08-03
Alectinib Has Been Launched in LaosAlectinib is an oral targeted therapeutic drug belonging to the class of ALK inhibitors. Unlike traditional chemotherapy, it does not act by kill···【more】
Recommended:122Release date: 2026-07-30
Lucius Pharmaceuticals Quizartinib (Quizartinib) Has Been Launched(1) Quizartinib is an oral tablet. The recommended dose is once daily, one tablet per day (the specific dose is de···【more】
Recommended:145Release date: 2026-07-29
Lucius version of Dacomitinib is now availableCutaneous adverse reactions and management strategies for DacomitinibRash and exfoliative skin reactions are highly characteristic adv···【more】
Recommended:164Release date: 2026-07-21
Lao PDR: Filgotinib Has Been LaunchedBefore initiating filgotinib treatment, strict screening for the following contraindications is mandatory; the presence of any one of these con···【more】
Recommended:170Release date: 2026-07-13
Lucius Pharmaceuticals' Pirtobrutinib Has Been LaunchedPirtobrutinib is an oral anticancer drug whose active ingredient is pirtobrutinib, belonging to the class of Bruton's···【more】
Recommended:195Release date: 2026-07-10
Lucius Pharmaceuticals (Lao) Co., Ltd. has launched a generic version of elagolix sodium (trade name LuciElag) for the treatment of moderate to severe pain associated with endometr···【more】
Recommended:217Release date: 2026-07-06
Contraindications for Bempedoic Acid (Nilemdo)Bempedoic acid (Nilemdo) is strictly contraindicated in the following situations: ①hypersensitivity to bempedoic acid or any excipient···【more】
Recommended:195Release date: 2026-07-03
MONDAY, June 15, 2026 — A study published online June 8 in Nature Medicine has found that apitegromab, through its selective inhibition of myostatin, can maintain lean body mass wh···【more】
Recommended:230Release date: 2026-06-24
On May 28, 2026, AstraZeneca announced that its immunotherapy drug Imfinzi (durvalumab) in combination with BCG (Bacillus Calmette-Guérin) induction and maintenance regimen has rec···【more】
Recommended:333Release date: 2026-06-01
On November 21, 2025, the U.S. Food and Drug Administration (FDA) approved the regimen of pembrolizumab (Keytruda, Merck & Co., Inc.) or pembrolizumab and berahyaluronidase alf···【more】
Recommended:654Release date: 2025-12-17

Lucius Pharmaceutical Co., Ltd., was established in 2020 in Vientiane, the capital of Laos. It aims to offer safe, effective, and affordable medicines globally. With a factory spanning 25,000 square meters, the company manufactures 200+ generic drugs in diverse therapeutic fields.
Address: No.26 Thongmang village, Xaythany district, Vientiane Capital, Laos
E-mail:laoslucius@gmail.com

Name: Lucius

Telegram name: Vira
No.:0085253923643
Telegram name: Vira
No.:0085253923643